Voices
Ryan Schoenfeld: Mark and Sontag Foundations Launch Multi-Organizational Partnership to Transform GBM Care
Ryan Schoenfeld/LinkedIn

Ryan Schoenfeld: Mark and Sontag Foundations Launch Multi-Organizational Partnership to Transform GBM Care

Ryan Schoenfeld, Chief Executive Officer at The Mark Foundation for Cancer Research, shared a post on LinkedIn:

“For decades, glioblastoma (GBM) has remained one of the most aggressive and treatment-resistant cancers, with a median survival rate that has barely budged. To change the future for these patients, we must accelerate the transition from discovery to breakthrough therapies.

Last week The Mark Foundation for Cancer Research, together with The Sontag Foundation, announced the launching of a new multi-organizational partnership that is funding five groundbreaking research projects aimed at transforming GBM care, awarding a total of $4M in new grants.

We are joined in this mission by a dedicated group of partners including Anne and Claude Berda Foundation, National Brain Tumor Society, SOUTHEASTERN BRAIN TUMOR FOUNDATION, and UNCLE KORY FOUNDATION.

By pooling our resources and aligning our expertise, we are enabling bold, cross-disciplinary science that addresses the extreme complexity of brain tumors. This year’s awarded teams are tackling GBM from every angle-from mapping chromosomal aneuploidies present in nearly every tumor cell to engineering next-generation CAR T cell therapies and identifying and validating new targets for immunotherapy.

Congratulations to the 2026 award recipients Rameen Beroukhim, William Kaelin Jr., Keith Ligon, Daniel Schramek, Jason Moffat, Antonio Chiocca, Marco Mineo, Justin Lathia, Daniel Wahl, Peter Sorger, and Christine Brown, and to their respective research institutions Broad Institute of MIT and Harvard, Dana-Farber Cancer Institute, Lunenfeld-Tanenbaum Research Institute, Sinai Health, The Hospital for Sick Children, Brigham and Women’s Hospital, Cleveland Clinic, University of Michigan, Harvard Medical School, City of Hope.

We are proud to support these investigators taking risks in their research in the quest to discover for better treatments for GBM.

Read more about their projects and our collaborative mission here.”

Other articles featuring Ryan Schoenfeld on OncoDaily.

Anne and Claude Berda Foundation Antonio Chiocca Brigham and Women's Hospital City of Hope Cleveland Clinic Dana-Farber Cancer Institute Daniel Schramek Daniel Wahl GBM glioblastoma Harvard Medical School Jason Moffat Justin Lathia Keith Ligon Lunenfeld-Tanenbaum Research Institute Marco Mineo National Brain Tumor Society Peter Sorger Rameen Beroukhim Ryan Schoenfeld Sinai Health SOUTHEASTERN BRAIN TUMOR FOUNDATION The Hospital for Sick Children The Mark Foundation for Cancer Research The Sontag Foundation UNCLE KORY FOUNDATION University of Michigan William Kaelin Jr.